Qualigen Therapeutics, Inc.
QLGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $38,777 | $332 | $30 | $1,175 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $3,312 | $2,230 | $2,011 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4,691 | $317 | $586 | $1,499 |
| Total Curr. Assets | $43,468 | $3,961 | $2,846 | $4,685 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $2 | $2 |
| Total NC Assets | $2 | $2 | $2 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $43,470 | $3,963 | $2,848 | $4,687 |
| Liabilities | – | – | – | – |
| Payables | $1,282 | $1,405 | $1,531 | $1,568 |
| Short-Term Debt | $3,237 | $3,617 | $844 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $404 | $594 | $440 | $439 |
| Total Curr. Liab. | $4,923 | $5,615 | $2,814 | $2,007 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | -$0 | $0 | $0 | $0 |
| Total NC Liab. | -$0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $4,923 | $5,615 | $2,814 | $2,007 |
| Equity | – | – | – | – |
| Pref Stock | $36,100 | $2,790 | $2,823 | $5,716 |
| Common Stock | $68 | $66 | $66 | $65 |
| Retained Earnings | -$129,430 | -$127,393 | -$125,708 | -$123,062 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $131,809 | $122,885 | $122,852 | $119,959 |
| Total Equity | $38,547 | -$1,652 | $33 | $2,679 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $43,470 | $3,963 | $2,848 | $4,687 |
| Net Debt | -$35,540 | $3,285 | $813 | -$1,175 |